Effects of Acupressure on Fatigue and Depression in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Quasi-Experimental Study

Table 4

Changes in VAS fatigue and VAS depression within groups over 5 times ( = 62).

Variable		T1^a	T2	T3	T4	T5		df
		M (SD)	M (SD)	M (SD)	M (SD)	M (SD)
Fatigue^b	Experimental group ( = 31)	3.12 (0.43)	3.28 (0.58)	3.58 (1.11)	3.91 (1.45)	5.25 (1.38)	16.907	4	.001
	Control group ( = 31)	2.58 (0.63)	3.72 (1.12)	4.12 (1.47)	4.73 (1.41)	6.15 (1.31)	48.559	4	.001
Depression^c	Experimental group ( = 31)	3.06 (0.22)	3.06 (0.20)	3.09 (0.80)	2.98 (0.90)	3.67 (1.10)	4.904	4	.004
	Control group ( = 31)	3.11 (0.30)	3.45 (0.55)	3.54 (0.61)	3.95 (1.04)	4.32 (1.01)	14.374	4	.001

Note. ^aPatients were followed up from initial treatment through the first five days of treating transcatheter arterial chemoembolization (TACE) (1, 2, 3, 4, and 5 days from treating TACE, respectively); T1 = 1 day from treating TACE; T2 = 2 days from treating TACE; T3 = 3 days from treating TACE; T4 = 4 days from treating TACE; T5 = 5 days from treating TACE; reference group was T1.
^bMeasured by VAS fatigue scale, range from 0 to 10.
^cMeasured by VAS depression scale, range from 0 to 10.